Form 4: Centessa Pharmaceuticals CEO Saurabh Saha Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
CEO Saurabh Saha disposed of 36,263 ordinary shares of Centessa Pharmaceuticals to cover tax withholding obligations related to vesting restricted share units.
Summary
- On March 31, 2024, Saurabh Saha, CEO of Centessa Pharmaceuticals plc, disposed of 36,263 ordinary shares.
- The disposal was to cover tax withholding obligations related to the vesting of restricted share units.
- The shares were sold at a price of $11.3.
- Following the transaction, Saha directly owns 868,187 ordinary shares.
- Saha also indirectly owns 38,000 ordinary shares through a trust where he and his spouse are trustees.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to share disposal for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in insider ownership.
- The disposal of shares by the CEO could be perceived negatively by some investors, although it is for tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of share disposal transaction |
| 04/02/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.